Report Detail

Nuclear medicine uses radiation to provide diagnostic information about the functioning of a person's specific organs, or to treat them. Diagnostic procedures using radioisotopes are now routine. Radiotherapy can be used to treat some medical conditions, especially cancer, using radiation to weaken or destroy particular targeted cells. The attributes of naturally decaying atoms, known as radioisotopes, give rise to several applications across many aspects of modern day life (see also information paper on The Many Uses of Nuclear Technology).There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions.
The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges.

Market Analysis and Insights: Global Medical Radioisotopes Market
The research report studies the Medical Radioisotopes market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Medical Radioisotopes market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Medical Radioisotopes Scope and Segment
The global Medical Radioisotopes market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Medical Radioisotopes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
by Type, the market is primarily split into
Mo-99
Co-60
Lutetium 177
by Application, this report covers the following segments
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
Global Medical Radioisotopes market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Medical Radioisotopes key players in this market include:
NRG
NTP Radioisotopes
ANSTO
IRE
Nordion
Curium Pharma
Eckert & Ziegler Strahlen
Polatom
China National Nuclear Corporation
IDB Holland


1 Market Overview of Medical Radioisotopes

  • 1.1 Medical Radioisotopes Market Overview
    • 1.1.1 Medical Radioisotopes Product Scope
    • 1.1.2 Market Status and Outlook
  • 1.2 Global Medical Radioisotopes Market Size Overview by Region 2015 VS 2020 VS 2026
  • 1.3 Global Medical Radioisotopes Market Size by Region (2015-2026)
  • 1.4 Global Medical Radioisotopes Historic Market Size by Region (2015-2020)
  • 1.5 Global Medical Radioisotopes Market Size Forecast by Region (2021-2026)
  • 1.6 Key Regions, Medical Radioisotopes Market Size YoY Growth (2015-2026)
    • 1.6.1 North America Medical Radioisotopes Market Size YoY Growth (2015-2026)
    • 1.6.2 Europe Medical Radioisotopes Market Size YoY Growth (2015-2026)
    • 1.6.3 Asia-Pacific Medical Radioisotopes Market Size YoY Growth (2015-2026)
    • 1.6.4 Latin America Medical Radioisotopes Market Size YoY Growth (2015-2026)
    • 1.6.5 Middle East & Africa Medical Radioisotopes Market Size YoY Growth (2015-2026)

2 Medical Radioisotopes Market Overview by Type

  • 2.1 Global Medical Radioisotopes Market Size by Type: 2015 VS 2020 VS 2026
  • 2.2 Global Medical Radioisotopes Historic Market Size by Type (2015-2020)
  • 2.3 Global Medical Radioisotopes Forecasted Market Size by Type (2021-2026)
  • 2.4 Mo-99
  • 2.5 Co-60
  • 2.6 Lutetium 177

3 Medical Radioisotopes Market Overview by Application

  • 3.1 Global Medical Radioisotopes Market Size by Application: 2015 VS 2020 VS 2026
  • 3.2 Global Medical Radioisotopes Historic Market Size by Application (2015-2020)
  • 3.3 Global Medical Radioisotopes Forecasted Market Size by Application (2021-2026)
  • 3.4 Nuclear Therapy
  • 3.5 Equipment Radioactive Source
  • 3.6 Diagnosis

4 Global Medical Radioisotopes Competition Analysis by Players

  • 4.1 Global Medical Radioisotopes Market Size (Million US$) by Players (2015-2020)
  • 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Medical Radioisotopes as of 2019)
  • 4.3 Date of Key Manufacturers Enter into Medical Radioisotopes Market
  • 4.4 Global Top Players Medical Radioisotopes Headquarters and Area Served
  • 4.5 Key Players Medical Radioisotopes Product Solution and Service
  • 4.6 Competitive Status
    • 4.6.1 Medical Radioisotopes Market Concentration Rate
    • 4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles and Key Data

  • 5.1 NRG
    • 5.1.1 NRG Profile
    • 5.1.2 NRG Main Business
    • 5.1.3 NRG Products, Services and Solutions
    • 5.1.4 NRG Revenue (US$ Million) & (2015-2020)
    • 5.1.5 NRG Recent Developments
  • 5.2 NTP Radioisotopes
    • 5.2.1 NTP Radioisotopes Profile
    • 5.2.2 NTP Radioisotopes Main Business and Company’s Total Revenue
    • 5.2.3 NTP Radioisotopes Products, Services and Solutions
    • 5.2.4 NTP Radioisotopes Revenue (US$ Million) (2015-2020)
    • 5.2.5 NTP Radioisotopes Recent Development and Reaction to Covid-19
  • 5.3 ANSTO
    • 5.5.1 ANSTO Profile
    • 5.3.2 ANSTO Main Business
    • 5.3.3 ANSTO Products, Services and Solutions
    • 5.3.4 ANSTO Revenue (US$ Million) & (2015-2020)
    • 5.3.5 IRE Recent Developments
  • 5.4 IRE
    • 5.4.1 IRE Profile
    • 5.4.2 IRE Main Business
    • 5.4.3 IRE Products, Services and Solutions
    • 5.4.4 IRE Revenue (US$ Million) & (2015-2020)
    • 5.4.5 IRE Recent Developments
  • 5.5 Nordion
    • 5.5.1 Nordion Profile
    • 5.5.2 Nordion Main Business
    • 5.5.3 Nordion Products, Services and Solutions
    • 5.5.4 Nordion Revenue (US$ Million) & (2015-2020)
    • 5.5.5 Nordion Recent Developments
  • 5.6 Curium Pharma
    • 5.6.1 Curium Pharma Profile
    • 5.6.2 Curium Pharma Main Business
    • 5.6.3 Curium Pharma Products, Services and Solutions
    • 5.6.4 Curium Pharma Revenue (US$ Million) & (2015-2020)
    • 5.6.5 Curium Pharma Recent Developments
  • 5.7 Eckert & Ziegler Strahlen
    • 5.7.1 Eckert & Ziegler Strahlen Profile
    • 5.7.2 Eckert & Ziegler Strahlen Main Business and Company’s Total Revenue
    • 5.7.3 Eckert & Ziegler Strahlen Products, Services and Solutions
    • 5.7.4 Eckert & Ziegler Strahlen Revenue (US$ Million) (2015-2020)
    • 5.7.5 Eckert & Ziegler Strahlen Recent Development and Reaction to Covid-19
  • 5.8 Polatom
    • 5.8.1 Polatom Profile
    • 5.8.2 Polatom Main Business
    • 5.8.3 Polatom Products, Services and Solutions
    • 5.8.4 Polatom Revenue (US$ Million) & (2015-2020)
    • 5.8.5 Polatom Recent Developments
  • 5.9 China National Nuclear Corporation
    • 5.9.1 China National Nuclear Corporation Profile
    • 5.9.2 China National Nuclear Corporation Main Business
    • 5.9.3 China National Nuclear Corporation Products, Services and Solutions
    • 5.9.4 China National Nuclear Corporation Revenue (US$ Million) & (2015-2020)
    • 5.9.5 China National Nuclear Corporation Recent Developments
  • 5.10 IDB Holland
    • 5.10.1 IDB Holland Profile
    • 5.10.2 IDB Holland Main Business
    • 5.10.3 IDB Holland Products, Services and Solutions
    • 5.10.4 IDB Holland Revenue (US$ Million) & (2015-2020)
    • 5.10.5 IDB Holland Recent Developments

6 North America

  • 6.1 North America Medical Radioisotopes Market Size by Country
  • 6.2 United States
  • 6.3 Canada

7 Europe

  • 7.1 Europe Medical Radioisotopes Market Size by Country
  • 7.2 Germany
  • 7.3 France
  • 7.4 U.K.
  • 7.5 Italy
  • 7.6 Russia
  • 7.7 Nordic
  • 7.8 Rest of Europe

8 Asia-Pacific

  • 8.1 Asia-Pacific Medical Radioisotopes Market Size by Region
  • 8.2 China
  • 8.3 Japan
  • 8.4 South Korea
  • 8.5 Southeast Asia
  • 8.6 India
  • 8.7 Australia
  • 8.8 Rest of Asia-Pacific

9 Latin America

  • 9.1 Latin America Medical Radioisotopes Market Size by Country
  • 9.2 Mexico
  • 9.3 Brazil
  • 9.4 Rest of Latin America

10 Middle East & Africa

  • 10.1 Middle East & Africa Medical Radioisotopes Market Size by Country
  • 10.2 Turkey
  • 10.3 Saudi Arabia
  • 10.4 UAE
  • 10.5 Rest of Middle East & Africa

11 Medical Radioisotopes Market Dynamics

  • 11.1 Industry Trends
  • 11.2 Market Drivers
  • 11.3 Market Challenges
  • 11.4 Market Restraints

12 Research Finding /Conclusion

    13 Methodology and Data Source

    • 13.1 Methodology/Research Approach
      • 13.1.1 Research Programs/Design
      • 13.1.2 Market Size Estimation
      • 13.1.3 Market Breakdown and Data Triangulation
    • 13.2 Data Source
      • 13.2.1 Secondary Sources
      • 13.2.2 Primary Sources
    • 13.3 Disclaimer

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Medical Radioisotopes. Industry analysis & Market Report on COVID-19 Impact on Global Medical Radioisotopes is a syndicated market report, published as COVID-19 Impact on Global Medical Radioisotopes Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Medical Radioisotopes market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,500.00
    $7,000.00
    2,716.00
    5,432.00
    3,262.00
    6,524.00
    540,015.00
    1,080,030.00
    295,120.00
    590,240.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report